Ayfer Alikaşifoğlu

1.9k total citations
99 papers, 1.2k citations indexed

About

Ayfer Alikaşifoğlu is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics. According to data from OpenAlex, Ayfer Alikaşifoğlu has authored 99 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Endocrinology, Diabetes and Metabolism, 38 papers in Molecular Biology and 24 papers in Genetics. Recurrent topics in Ayfer Alikaşifoğlu's work include Growth Hormone and Insulin-like Growth Factors (19 papers), Sexual Differentiation and Disorders (18 papers) and Hypothalamic control of reproductive hormones (11 papers). Ayfer Alikaşifoğlu is often cited by papers focused on Growth Hormone and Insulin-like Growth Factors (19 papers), Sexual Differentiation and Disorders (18 papers) and Hypothalamic control of reproductive hormones (11 papers). Ayfer Alikaşifoğlu collaborates with scholars based in Türkiye, United States and United Kingdom. Ayfer Alikaşifoğlu's co-authors include Nurgün Kandemir, Alev Özön, E. Nazlı Gönç, Nurgün Kandemir, N Yordam, Nazlı Gönç, Hüseyin Demirbilek, Yaşar Şen, Doğuş Vurallı and Igor O. Nasonkin and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Ayfer Alikaşifoğlu

96 papers receiving 1.1k citations

Peers

Ayfer Alikaşifoğlu
Teoman Akçay Türkiye
Ayfer Alikaşifoğlu
Citations per year, relative to Ayfer Alikaşifoğlu Ayfer Alikaşifoğlu (= 1×) peers Teoman Akçay

Countries citing papers authored by Ayfer Alikaşifoğlu

Since Specialization
Citations

This map shows the geographic impact of Ayfer Alikaşifoğlu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ayfer Alikaşifoğlu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ayfer Alikaşifoğlu more than expected).

Fields of papers citing papers by Ayfer Alikaşifoğlu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ayfer Alikaşifoğlu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ayfer Alikaşifoğlu. The network helps show where Ayfer Alikaşifoğlu may publish in the future.

Co-authorship network of co-authors of Ayfer Alikaşifoğlu

This figure shows the co-authorship network connecting the top 25 collaborators of Ayfer Alikaşifoğlu. A scholar is included among the top collaborators of Ayfer Alikaşifoğlu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ayfer Alikaşifoğlu. Ayfer Alikaşifoğlu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
İnce, Deni̇z İnal, Deni̇z Doğru, Ayfer Alikaşifoğlu, et al.. (2022). Exercise performance in children and adolescents with cystic fibrosis with and without abnormal glucose tolerance: a single center cross-sectional study. Physiotherapy Theory and Practice. 40(2). 230–240. 3 indexed citations
3.
Gönç, E. Nazlı, et al.. (2022). Psychosocial Impact of the COVID-19 Pandemic on Children with Congenital Adrenal Hyperplasia and Their Families. Turkish Archives of Pediatrics. 57(6). 621–629. 1 indexed citations
4.
Çiftçi, Arbay Ö., Canan Akyüz, M. Tezer Kutluk, et al.. (2021). Adrenocortical tumours in children: a review of surgical management at a tertiary care centre. ANZ Journal of Surgery. 91(5). 992–999. 5 indexed citations
5.
Alikaşifoğlu, Ayfer, et al.. (2021). Management of prolactinomas in children and adolescents; which factors define the response to treatment?. Pituitary. 25(1). 167–179. 7 indexed citations
6.
Emiralioğlu, Nagehan, Alev Özön, Dilber Ademhan Tural, et al.. (2021). Sleep disordered breathing in patients with Prader willi syndrome: Impact of underlying genetic mechanism. Respiratory Medicine. 187. 106567–106567. 5 indexed citations
7.
Alikaşifoğlu, Ayfer, Nurgün Kandemir, Büşra Aydın, et al.. (2020). Novel insights into diabetes mellitus due to DNAJC3 defect: Evolution of neurological and endocrine phenotype in the pediatric age group. Pediatric Diabetes. 21(7). 1176–1182. 8 indexed citations
8.
Alikaşifoğlu, Ayfer, et al.. (2020). Obstructive sleep apnea in children with hypothalamic obesity: Evaluation of possible related factors. Pediatric Pulmonology. 55(12). 3532–3540. 4 indexed citations
9.
Özön, Alev, et al.. (2020). Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism. Journal of Clinical Research in Pediatric Endocrinology. 13(3). 269–275. 1 indexed citations
10.
Fu, Jiao, E. Nazlı Gönç, Laura Sillers, et al.. (2020). Clinical and Molecular Analysis in 2 Families With Novel Compound Heterozygous SBP2 (SECISBP2) Mutations. The Journal of Clinical Endocrinology & Metabolism. 105(3). e6–e11. 11 indexed citations
11.
Gönç, E. Nazlı, Ekim Z. Taşkıran, Gülen Eda Ütine, et al.. (2020). Genetic IGF1R defects: new cases expand the spectrum of clinical features. Journal of Endocrinological Investigation. 43(12). 1739–1748. 4 indexed citations
12.
Vurallı, Doğuş, et al.. (2019). Treatment with Depot Leuprolide Acetate in Girls with Idiopathic Precocious Puberty: What Parameter should be Used in Deciding on the Initial Dose?. Journal of Clinical Research in Pediatric Endocrinology. 12(1). 37–44. 5 indexed citations
13.
Vurallı, Doğuş, Deniz Çağdaş, Hülya Demır, et al.. (2019). Unusual Presentation of Autoimmune Polyglandular Syndrome Type 1 (aps1). 92.
14.
Vurallı, Doğuş, et al.. (2017). Clinical and laboratory parameters predicting a requirement for the reevaluation of growth hormone status during growth hormone treatment. Growth Hormone & IGF Research. 34. 31–37. 8 indexed citations
15.
Alikaşifoğlu, Ayfer, Nurgün Kandemir, Munis Dündar, et al.. (2016). A Nonvirilized form of Classic 3[beta]-Hydroxysteroid Dehydrogenase Deficiency Due to a Homozygous S218P Mutation in the HSD3B2 Gene in a Girl with Classic Phenylketonuria. 86. 1 indexed citations
16.
Demirbilek, Hüseyin, E. Nazlı Gönç, Alev Özön, Ayfer Alikaşifoğlu, & Nurgün Kandemir. (2012). Evaluation of serum kisspeptin levels in girls in the diagnosis of central precocious puberty and in the assessment of pubertal suppression. Journal of Pediatric Endocrinology and Metabolism. 25(3-4). 313–6. 21 indexed citations
17.
Kandemir, Nurgün, et al.. (2008). Final Heights of Boys with Normal Growth Hormone Responses to Provocative Tests Following Priming. Journal of Pediatric Endocrinology and Metabolism. 21(10). 963–71. 15 indexed citations
18.
Andıran, Nesibe, et al.. (2008). Cyclic Pamidronate Therapy in Children with Osteogenesis Imperfecta: Results of Treatment and Follow-up After Discontinuation. Journal of Pediatric Endocrinology and Metabolism. 21(1). 63–72. 19 indexed citations
19.
Çeti̇nkaya, Semra, et al.. (2007). Inappropriate Use of Potent Topical Glucocorticoids in Infants. Journal of Pediatric Endocrinology and Metabolism. 20(2). 219–25. 26 indexed citations
20.
Özen, Seza, et al.. (2001). Higher frequency of allele 2 of the interleukin-1 receptor antagonist gene in patients with juvenile idiopathic arthritis. Arthritis & Rheumatism. 44(10). 2387–2391. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026